- Home
- BBIO vs MMYT Comparison
BBIO vs MMYT Comparison
Compare BBIO & MMYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- MMYT
- Stock Information
- Founded
- BBIO 2015
- MMYT 2000
- Country
- BBIO United States
- MMYT India
- Employees
- BBIO N/A
- MMYT N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- MMYT Transportation Services
- Sector
- BBIO Health Care
- MMYT Consumer Discretionary
- Exchange
- BBIO Nasdaq
- MMYT Nasdaq
- Market Cap
- BBIO 9.4B
- MMYT 9.0B
- IPO Year
- BBIO 2019
- MMYT 2010
- Fundamental
- Price
- BBIO $55.32
- MMYT $92.62
- Analyst Decision
- BBIO Strong Buy
- MMYT Strong Buy
- Analyst Count
- BBIO 16
- MMYT 3
- Target Price
- BBIO $64.44
- MMYT $120.00
- AVG Volume (30 Days)
- BBIO 2.0M
- MMYT 922.9K
- Earning Date
- BBIO 11-11-2025
- MMYT 10-21-2025
- Dividend Yield
- BBIO N/A
- MMYT N/A
- EPS Growth
- BBIO N/A
- MMYT N/A
- EPS
- BBIO N/A
- MMYT 0.86
- Revenue
- BBIO $235,812,000.00
- MMYT $992,663,000.00
- Revenue This Year
- BBIO $115.46
- MMYT $23.37
- Revenue Next Year
- BBIO $65.03
- MMYT $21.46
- P/E Ratio
- BBIO N/A
- MMYT $109.37
- Revenue Growth
- BBIO 7.62
- MMYT 18.13
- 52 Week Low
- BBIO $21.72
- MMYT $81.84
- 52 Week High
- BBIO $55.32
- MMYT $123.00
- Technical
- Relative Strength Index (RSI)
- BBIO 59.91
- MMYT 42.34
- Support Level
- BBIO $52.97
- MMYT $92.08
- Resistance Level
- BBIO $55.13
- MMYT $96.54
- Average True Range (ATR)
- BBIO 1.58
- MMYT 2.71
- MACD
- BBIO 0.16
- MMYT -0.26
- Stochastic Oscillator
- BBIO 84.41
- MMYT 13.90
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About MMYT MakeMyTrip Limited
MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.